Open Access. Powered by Scholars. Published by Universities.®
Alternative and Complementary Medicine Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 6 of 6
Full-Text Articles in Alternative and Complementary Medicine
Homoeopathic Pathogenetic Trial Of Cuprum Aceticum: A Multicentric, Double-Blind, Randomized, Placebo Controlled Trial, Pritha Mehra, Ashish Mahajan, Anil Vichitra, B. Rajakumar, Jai Singh, Kishan Banoth, B. Arya, Anil Khurana
Homoeopathic Pathogenetic Trial Of Cuprum Aceticum: A Multicentric, Double-Blind, Randomized, Placebo Controlled Trial, Pritha Mehra, Ashish Mahajan, Anil Vichitra, B. Rajakumar, Jai Singh, Kishan Banoth, B. Arya, Anil Khurana
Indian Journal of Research in Homoeopathy
Background: Although the symptomatology of Cuprum metallicum is quite vast, its other salts have fragmentary proving. Thus, homoeopathic pathogenetic trial for Cuprum aceticum (Cu acet.) was taken up. Objective: To elicit the pathogenetic response to Cu acet. in homoeopathic potencies on healthy human provers. Materials and Methods: A multi-center, double-blind randomized, placebo controlled, trial was conducted at three centers of Central Council for Research in Homoeopathy. Proving was conducted on 50 relatively healthy provers selected after conducting the Pretrial Medical Examination. All the provers were given placebo during the first phase of the trial. In the next two phases, Cu …
Homoeopathic Drug Proving Of Mangolia Grandiflora: A Randomised Double Blind Placebo-Controlled Trial, Goutam Rakshit, Vichitra A, Rajpal Singh, Amulya Sahoo, Sujata Choudhury, Vinay Singh
Homoeopathic Drug Proving Of Mangolia Grandiflora: A Randomised Double Blind Placebo-Controlled Trial, Goutam Rakshit, Vichitra A, Rajpal Singh, Amulya Sahoo, Sujata Choudhury, Vinay Singh
Indian Journal of Research in Homoeopathy
Objective: This study was carried out to elicit the pathogenetic response of the drug Magnolia grandiflora in homoeopathic potencies on apparently healthy human beings. Materials and Methods: Drug Magnolia grandiflora was proved by the Central Council for Research in Homoeopathy (CCRH) through a double-blind placebo-controlled method. The study was conducted at three centres. The drug was proved in two potencies (6C and 30C) on 48 apparently healthy volunteers who were selected after conducting pre-trial medical examinations by the medical specialists and routine laboratory investigations. In the first phase, volunteers were given 56 doses (4 doses per day for 14 days) …
Homoeopathic Pathogenetic Trial Of Withania Somnifera: A Multicentric, Double-Blind, Randomised, Placebo-Controlled Trial, Pritha Mehra, Anil Khurana, Renu Mittal, Bhopal Arya, Rajpal Rajpal, Raj Manchanda, Karuna Singh, Anil Vichitra, Goutam Rakshit
Homoeopathic Pathogenetic Trial Of Withania Somnifera: A Multicentric, Double-Blind, Randomised, Placebo-Controlled Trial, Pritha Mehra, Anil Khurana, Renu Mittal, Bhopal Arya, Rajpal Rajpal, Raj Manchanda, Karuna Singh, Anil Vichitra, Goutam Rakshit
Indian Journal of Research in Homoeopathy
Background: Homoeopathic drug proving being the first step in finding the pathogenetic powers of a drug is an integral part of Homoeopathic system of medicine. Objective: To elicit the pathogenetic response of Withania somnifera in homoeopathic potencies on healthy human provers. Materials and Methods: A multicentre, randomised, double-blind, placebo-controlled trial was conducted at four centres under Central Council for Research in Homoeopathy. Proving was conducted on 63 relatively healthy provers. All the provers were given 12 doses of placebo divided into 4 doses/day for 3 days during the first phase of the trial. After randomisation, 43 provers in the intervention …
A Multicentric, Double-Blind Randomized, Homoeopathic Pathogenetic Trial Of Allium Sativum, Raj Manchanda, Anil Khurana, Raj Pal, Bhopal Arya, Anil Vichitra, P Mohanan, Pritha Mehra, Shilpa Sharma
A Multicentric, Double-Blind Randomized, Homoeopathic Pathogenetic Trial Of Allium Sativum, Raj Manchanda, Anil Khurana, Raj Pal, Bhopal Arya, Anil Vichitra, P Mohanan, Pritha Mehra, Shilpa Sharma
Indian Journal of Research in Homoeopathy
Background: Homoeopathic drug proving is an integral part of Homoeopathic System of Medicine. It is the first step in finding out the pathogenetic powers of a drug. Objective: To elicit the pathogenetic response to Allium sativum in homoeopathic potencies on healthy human provers. Materials and Methods: A multi-center randomized, placebo-controlled, double-blind trial was conducted at two centers of the Central Council for Research in Homoeopathy (CCRH). Proving was conducted on 33 healthy provers after the pretrial medical examination. All the provers were given 12 doses of placebo divided in 4 doses/day for 3 days during the first phase of the …
A Multi-Centric Double-Blind Homoeopathic Pathogenetic Trial Of Cyclosporin, Goutam Rakshit, A Vichitra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
A Multi-Centric Double-Blind Homoeopathic Pathogenetic Trial Of Cyclosporin, Goutam Rakshit, A Vichitra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
Indian Journal of Research in Homoeopathy
Objective : To elicit the pathogenetic response of the drug Cyclosporin in homoeopathic potencies on apparently healthy human beings. Material and Methods : The drug Cyclosporin was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled trial. The study was conducted in two centres. The drug was proved in two potencies (6C and 30C) on 50 apparently healthy volunteers who were selected after conducting pre-trial medical examinations by the medical specialists and routine laboratory investigations. In the first phase the volunteers were given 56 doses (4 doses per day for 14 days) of placebo. In the next …
A Multi-Centric Double-Blind Randomized Homoeopathic Pathogenetic Trial Of Gymnema Sylvestre, Goutam Rakshit, J Singh, S Pathak, Ch Banoth, P Chandra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
A Multi-Centric Double-Blind Randomized Homoeopathic Pathogenetic Trial Of Gymnema Sylvestre, Goutam Rakshit, J Singh, S Pathak, Ch Banoth, P Chandra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
Indian Journal of Research in Homoeopathy
Objective: To elicit the pathogenetic response of Gymnema sylvestre in homoeopathic potencies on apparently healthy human volunteers. Methodology: Gymnema sylvestre was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled method. The study was carried out at four centers. The drug was proved in two potencies (6C and 30C) on 63 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. In the first phase volunteers were given 56 doses (04 doses per day for 14 days) of placebo. In the next two phases 56 doses (04 doses …